◀ Back to CASP8
CASP8 — DAXX
Pathways - manually collected, often from reviews:
-
BioCarta hiv-1 nef: negative effector of fas and tnf:
FAS/FADD/DAXX/ASK1/Caspase 8/Caspase 8/FAS L complex (FAS-FADD-DAXX-MAP3K5-CASP8-FASLG)
→
Caspase 8/Caspase 8/Caspase 8/Caspase 8 complex (CASP8)
(modification, activates)
-
BioCarta hiv-1 nef: negative effector of fas and tnf:
FAS/FADD/DAXX/ASK1/Caspase 8/Caspase 8/FAS L complex (FAS-FADD-DAXX-MAP3K5-CASP8-FASLG)
→
I-FLICE (CFLAR)
(modification, activates)
-
BioCarta hiv-1 nef: negative effector of fas and tnf:
TNFSF6 (FASLG)
→
FAS/FADD/DAXX/ASK1/Caspase 8/Caspase 8 complex (FAS-FADD-DAXX-MAP3K5-CASP8)
(modification, collaborate)
-
BioCarta hiv-1 nef: negative effector of fas and tnf:
TNFSF6 (FASLG)
→
FAS/FADD/DAXX/ASK1/Caspase 8/Caspase 8/FAS L complex (FAS-FADD-DAXX-MAP3K5-CASP8-FASLG)
(modification, collaborate)
-
BioCarta hiv-1 nef: negative effector of fas and tnf:
FAS/FADD/DAXX/ASK1/Caspase 8/Caspase 8 complex (FAS-FADD-DAXX-MAP3K5-CASP8)
→
FAS/FADD/DAXX/ASK1/Caspase 8/Caspase 8/FAS L complex (FAS-FADD-DAXX-MAP3K5-CASP8-FASLG)
(modification, collaborate)
-
NCI Pathway Database HIV-1 Nef: Negative effector of Fas and TNF-alpha:
TNFR1A/Caspase 2/TNF-alpha/FADD/TRADD/RIP/cIAP2/TRAF1/TRAF2/Ask1/RAIDD complex (TNFRSF1A-CASP2-TNF-FADD-TRADD-RIPK1-MAP3K5-TRAF1-TRAF2-BIRC3-CRADD)
→
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG complex (FASLG-CASP8-MAP3K5-FAS-DAXX-FADD)
(modification, activates)
Micheau et al., Cell 2003, Yang et al., Cell 1997, Saitoh et al., EMBO J 1998, Chang et al., Science 1998
-
NCI Pathway Database HIV-1 Nef: Negative effector of Fas and TNF-alpha:
FASLG (FASLG)
→
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8 complex (FAS-FADD-DAXX-MAP3K5-CASP8)
(modification, collaborate)
Juo et al., Curr Biol 1998
-
NCI Pathway Database HIV-1 Nef: Negative effector of Fas and TNF-alpha:
FASLG (FASLG)
→
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG complex (FASLG-CASP8-MAP3K5-FAS-DAXX-FADD)
(modification, collaborate)
Juo et al., Curr Biol 1998
-
NCI Pathway Database HIV-1 Nef: Negative effector of Fas and TNF-alpha:
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8 complex (FAS-FADD-DAXX-MAP3K5-CASP8)
→
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG complex (FASLG-CASP8-MAP3K5-FAS-DAXX-FADD)
(modification, collaborate)
Juo et al., Curr Biol 1998
-
NCI Pathway Database HIV-1 Nef: Negative effector of Fas and TNF-alpha:
c-FLIP (CFLAR)
→
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG complex (FASLG-CASP8-MAP3K5-FAS-DAXX-FADD)
(modification, inhibits)
Medema et al., EMBO J 1997
-
NCI Pathway Database HIV-1 Nef: Negative effector of Fas and TNF-alpha:
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG complex (FASLG-CASP8-MAP3K5-FAS-DAXX-FADD)
→
Caspase 8 (4 units) complex (CASP8)
(modification, activates)
Medema et al., EMBO J 1997
Text-mined interactions from Literome
Song et al., J Cell Biochem 2004
:
Daxx fragment induced activation of
caspase-9 and -3 was
mediated through the apoptosis signal regulating kinase 1 ( ASK1 ) -MEK-c-Jun-N-terminal kinase (JNK)/p38-Bax pathway
Kanamori et al., Am J Physiol Heart Circ Physiol 2007
(Myocardial Infarction...) :
Ten days post-MI, apoptosis among granulation tissue cells was significantly suppressed in the olmesartan treated hearts, where expression of Fas, Bax, procaspase-3, and
Daxx and
activation of
caspase-3 , c-Jun NH ( 2 ) -terminal kinase, and c-Jun were all significantly attenuated